Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2024 (in €M):
Metric | Min | Max | Average | Contr. |
---|---|---|---|---|
Sales | 2,037 | 2,135 | 2,087 | 16 |
Adjusted EBITDA | 457 | 485 | 471 | 15 |
Adjusted EBITA | 373 | 388 | 381 | 5 |
Cash Net Profit | 218 | 232 | 227 | 4 |
Cash EPS | 1,15 | 1,22 | 1,19 | 6 |
Net Working Capital | 345 | 497 | 397 | 12 |
Net Debt | 967 | 1,163 | 1,075 | 14 |
FY 2025 (in €M):
Metric | Min | Max | Average | Contr. |
---|---|---|---|---|
Sales | 2,141 | 2,311 | 2,208 | 15 |
Adjusted EBITDA | 489 | 541 | 518 | 14 |
Adjusted EBITA | 422 | 445 | 429 | 5 |
Cash Net Profit | 254 | 268 | 262 | 4 |
Cash EPS | 1,33 | 1,43 | 1,38 | 6 |
Net Working Capital | 369 | 527 | 421 | 12 |
Net Debt | 858 | 1,088 | 953 | 13 |
* Data as of 14.03.2024
Notes:
- A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates since the company held its FY2023 results (16 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.